Fusion Pharmaceuticals Inc (FUSN)
21.50
+0.08
(+0.40%)
USD |
NASDAQ |
May 02, 16:00
21.50
0.00 (0.00%)
After-Hours: 20:00
Fusion Pharmaceuticals Cash and Short Term Investments (Quarterly): 233.61M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 233.61M |
| September 30, 2023 | 191.35M |
| June 30, 2023 | 198.10M |
| March 31, 2023 | 209.84M |
| December 31, 2022 | 170.87M |
| September 30, 2022 | 205.48M |
| June 30, 2022 | 198.42M |
| March 31, 2022 | 196.81M |
| December 31, 2021 | 200.80M |
| Date | Value |
|---|---|
| September 30, 2021 | 192.62M |
| June 30, 2021 | 178.52M |
| March 31, 2021 | 227.22M |
| December 31, 2020 | 222.40M |
| September 30, 2020 | 291.95M |
| June 30, 2020 | 318.89M |
| March 31, 2020 | 67.42M |
| December 31, 2019 | 65.34M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
65.34M
Minimum
Dec 2019
318.89M
Maximum
Jun 2020
198.21M
Average
198.42M
Median
Jun 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| AstraZeneca PLC | 8.021B |
| Landos Biopharma Inc | 37.50M |
| Acasti Pharma Inc | 25.11M |
| Aurinia Pharmaceuticals Inc | 350.49M |
| Edesa Biotech Inc | 4.268M |